Team:Virginia

From 2013.igem.org

(Difference between revisions)
 
(44 intermediate revisions not shown)
Line 1: Line 1:
-
{{VirginiaBanner}}
+
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"-->
-
{|align="justify"
+
<html xmlns="http://www.w3.org/1999/xhtml">
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
<head>
-
!align="center"|[[Team:Virginia|Home]]
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
-
!align="center"|[[Team:Virginia/Team|Team]]
+
<title>VGEM Welcomes You!</title>
-
!align="center"|[https://igem.org/Team.cgi?year=2013&team_name=Virginia Official Team Profile]
+
<link href="http://fonts.googleapis.com/css?family=Open+Sans:400,300,600,700|Raleway:400,700,200,300,900,800" rel="stylesheet" type="text/css">
-
!align="center"|[[Team:Virginia/Project|Project]]
+
<style type="text/css">
-
!align="center"|[[Team:Virginia/Human_Practices|Human Practices]]
+
@import url("Raleway/stylesheet.css");
-
!align="center"|[[Team:Virginia/Parts|Parts Submitted to the Registry]]
+
body,td,th {
-
!align="center"|[[Team:Virginia/Modeling|Modeling]]
+
font-family: Raleway, sans-serif;
-
!align="center"|[[Team:Virginia/Notebook|Notebook]]
+
        font-weight:200;
-
!align="center"|[[Team:Virginia/Safety|Safety]]
+
}
-
!align="center"|[[Team:Virginia/Attributions|Attributions]]
+
body {
-
|}
+
background-color: #black;
-
<html>
+
color: white;
-
<h3>Preliminary Description:</h3>
+
text-align: left;
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Uneven cellular division in bacteria can yield a normal parent cell and a smaller “minicell”. At 400 nm, minicells are smaller than regular bacteria. They lack chromosomal DNA, which means they cannot replicate and cause infection. On the other hand, they still retain and express plasmid genes, which allow them to carry out a variety of functions (Mugridge). Additionally, minicells maintain a proton gradient and have membrane stability, while also containing proteins from the parent bacteria (Frazer). Since they retain plasma membrane components, these cells can be coupled with antibodies for highly-specific receptor targeting (MacDiarmid). These unique qualities make minicells a viable and safer alternative to comparable chassis such as live E. coli and liposomes.
+
vertical-align: baseline;
-
</p>
+
        margin:0 auto;
 +
        width:95%;
 +
        overflow:scroll;
 +
font-size:12px;
 +
}
 +
</style>
 +
<style media="screen" type="text/css">
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Minicells offer great promise for synthetic biology. To harness this potential, we aim to create a standard BioBrick that induces minicell formation by E. coli cells, and designed additional safeguards to make our chassis as safe as possible. Research has shown that overproducing the tubulin-like FtsZ protein leads to minicell formation (Ward). Accordingly, we designed our basic BioBrick to contain the FtsZ gene under the control of an IPTG-inducible promoter, so that we can simply overexpress FtsZ to produce minicells. We also decided to model the optimal amount of FtsZ overexpression necessary for robust minicell production.
+
/*hide default igem banner and reformat style into blank slate*/
-
</p>
+
#globalWrapper {width: 100%;}
 +
#top-section {width: 100%; height:0px; border:none;}
 +
#p-logo {display:none; visibility:hidden;}
 +
#search-controls {display:none;}
 +
#menubar a {color:#FFFFFF;}
 +
#menubar a:hover{text-decoration:none; color:#52749C;}
 +
.left-menu {background-color:#FFFFFF; margin:0px 0px 0px 0px; padding:0;}
 +
.left-menu ul {background-color:#FFFFFF; margin:0; padding:0;}
 +
.right-menu ul li a {background-color:#CCCCCC;}
 +
.printfooter {display:none;}
 +
#footer-box {border:none;}
 +
#catlinks {display:none;}
 +
.firstHeading {display:none;}
 +
#content {width: 100%; border:none;}
 +
#bodyContent {border:none;}
 +
</style>
 +
<style media="screen" type="text/css">
 +
@font-face {
 +
font-family: 'Raleway';
 +
src: url('<link href="http://fonts.googleapis.com/css?family=Open+Sans:400,300,600,700|Raleway:400,700,200,300,900,800" rel="stylesheet" type="text/css">') format('woff');
 +
}
 +
.igemlogo {
 +
position:absolute;
 +
z-index:200;
 +
padding:20px;
 +
}
 +
.slidingpics {
 +
background-color: #000;
 +
clear: both;
 +
height: 420px;
 +
margin-left: auto;
 +
margin-left: auto;
 +
padding:10px;
 +
position:relative;
 +
z-index:1;
 +
        overflow:hidden;
 +
        padding-bottom:30px;
 +
}
 +
.fourfocus {
 +
background-color: #000;
 +
color: white;
 +
padding: 15px;
 +
height: 380px;
 +
margin-left: auto;
 +
margin-right: auto;
 +
padding-left:50px;
 +
        overflow:hidden;
 +
}
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are numerous precautions that can be implemented to make minicells even safer for medical use. Among these, we have chosen to incorporate  the gene for the Ail protein from Yersinia pestis to prevent complement deposition in human serum (Kolodziejek). We have also explored the possibility of sialylation using sialic acid on our chassis, which would lower our minicells’ immunogenicity. Both the Ail protein and the sialic acid can then be expressed in concert with the original FtsZ BioBrick to create safe minicells for use as chassis. All of these genes would then finally be transformed into an IpxM strain, which is safer than regular E.coli due to a mutation in the lipid A of its lipopolysaccharide (Anisimov). Since LPS is a major target of the complement system, the IpxM strain would thus help the minicells avoid an adverse immune response.
+
.fourfocus p {
-
</p>
+
color:#6A6A6A;
 +
}
 +
.fourfocus h2 {
 +
color: #FFFFFF;
 +
}
 +
.bottom {
 +
background-color: #000;
 +
color: #FFFFFF;
 +
padding: 35px 15px 15px 15px;
 +
height: 700px;
 +
clear: both;
 +
border-top-width: 1px;
 +
border-top-style: solid;
 +
border-top-color: rgba(153,153,153,0.7);
 +
}
 +
.footer {
 +
background-color: #000000;
 +
padding: 5px;
 +
text-align: center;
 +
display: block;
 +
font-size: 12px;
 +
color: #FFFFFF;
 +
}
 +
.footer h3 {
 +
font-size: 18px;
 +
text-transform: capitalize;
 +
text-align: center;
 +
border-bottom-width: thin;
 +
border-bottom: 1px solid rgba(255,255,255,0.3);
 +
color:#FFFFFF;
 +
}
 +
.footer a {
 +
text-decoration:none;
 +
color: #E94730;
 +
}
 +
.footer a:hover {
 +
color: blue;
 +
}
 +
#picbox {
 +
margin-left:auto;
 +
margin-right:auto;
 +
width:1000px;
 +
padding-top:50px;
 +
        overflow:hidden;
 +
}
 +
#boxes {
 +
width: 1000px;
 +
margin-left: auto;
 +
margin-right:auto;
 +
        overflow:hidden;
 +
}
 +
#fbox1 {
 +
float: left;
 +
width: 235px;
 +
margin-right: 20px;
 +
text-align:center;
 +
margin-left:auto;
 +
}
 +
#fbox2 {
 +
float: left;
 +
width: 235px;
 +
margin-right: 20px;
 +
text-align:center;
 +
}
 +
#fbox3 {
 +
float: left;
 +
width: 235px;
 +
text-align:center;
 +
margin-right: 20px;
 +
}
 +
#fbox4 {
 +
float: left;
 +
width: 235px;
 +
text-align:center;
 +
}
 +
.topbanner {
 +
background-color: #000000;
 +
padding: 5px;
 +
height: 250px;
 +
position:relative;
 +
z-index:100;
 +
}
 +
#logo {
 +
height: 110px;
 +
margin: 30px auto 0px auto;
 +
}
 +
#VGEM, #logo p {
 +
margin: 0;
 +
padding: 0;
 +
}
 +
#VGEM {
 +
text-align: center;
 +
text-transform: uppercase;
 +
color:#FFFFFF;
 +
}
 +
#VGEM span {
 +
color: #E94730;
 +
}
 +
#logo p#VGEM a {
 +
font-size: 60px;
 +
color: #FFF;
 +
        font-weight:400;
 +
}
 +
#logo p {
 +
text-align: center;
 +
text-transform: uppercase;
 +
font-size: 25px;
 +
font-family: 'Raleway', sans-serif;
 +
color: #595959;
 +
}
 +
#logo p a {
 +
color:#595959;
 +
}
 +
#logo a {
 +
border: none;
 +
background: none;
 +
text-decoration: none;
 +
color: #1F1F1F;
 +
}
 +
#menu11 ul {
 +
text-transform: uppercase;
 +
font-size: 18px;
 +
line-height: 1.2em;
 +
clear: both;
 +
margin-left: auto;
 +
    margin-right:auto;
 +
    height:70px;
 +
    width:900px;       
 +
}
 +
#menu11 ul li{
 +
    display:block;
 +
    text-decoration:none;
 +
    padding:0px 0px 0px 10px;
 +
    width:150px;
 +
    height:55px;
 +
    border-left:6px dotted #fff;
 +
    float:left;
 +
}
 +
#menu11 ul li span{
 +
    display:block;
 +
}
 +
#menu11 ul li span.title{
 +
    color:#fff;
 +
list-style-type: none;
 +
}
 +
#menu11 ul li:hover{
 +
    border-left:10px dotted #E94730;
 +
}
 +
#menu11 ul li:hover span.title{
 +
list-style-type: none;
 +
}
 +
#menu11 ul li span.text{
 +
color: #325281;
 +
font-size: 14px;
 +
letter-spacing: 0px;
 +
visibility: hidden;
 +
line-height: 0px;
 +
padding-top: 8px;
 +
list-style-type: square;
 +
        background-color: #000000;
 +
        padding-bottom:2px;
 +
        padding-left:2px;
 +
        border-radius:10px;
 +
}
 +
#menu11 ul li:hover span.text{
 +
    visibility:visible;
 +
}
 +
#menu11 ul li:hover span.text a{
 +
    text-decoration:none;
 +
color:#66CCFF;
 +
}
 +
#images {
 +
    width: 900px;
 +
    height: 350px;
 +
    overflow: hidden;
 +
    position: relative;
 +
    margin: 20px auto;
 +
    }
 +
    #images img {
 +
    width: 900px;
 +
    height: 350px;
 +
    position: absolute;
 +
    top: 0;
 +
    left: -400px;
 +
    z-index: 2;
 +
    opacity: 0;
 +
    transition: all linear 500ms;
 +
    -o-transition: all linear 500ms;
 +
    -moz-transition: all linear 500ms;
 +
    -webkit-transition: all linear 500ms;
 +
    }
 +
    #images img:target {
 +
    left: 0;
 +
    z-index: 9;
 +
    opacity: 1;
 +
    }
 +
    #images img:first-child {
 +
    left: 0;
 +
    opacity:.9;
 +
    z-index:8;
 +
    }
 +
    #slider {
 +
    width:200px;
 +
    margin-left:auto;
 +
    margin-right:auto;
 +
}
 +
    #slider a {
 +
    text-decoration: none;
 +
    background: #E3F1FA;
 +
    border: 1px solid #C6E4F2;
 +
    padding: 4px 6px;
 +
    color: #222;
 +
    }
 +
    #slider a:hover {
 +
    background: #C6E4F2;
 +
    }
 +
/** WRAPPER */
 +
#featured-wrapper {
 +
overflow: hidden;
 +
width:1000px;
 +
padding: 25px 50px;
 +
background: #E54732;
 +
color: #2D2D2D;
 +
margin-left:auto;
 +
margin-right:auto;
 +
}
 +
#btitle
 +
{
 +
margin-bottom: 30px;
 +
text-transform: uppercase;
 +
font-weight: 300;
 +
font-size: 22px;
 +
color: #FFF;
 +
}
 +
#featured-wrapper span
 +
{
 +
font-size: 18px !important;
 +
color: #323232;
 +
}
 +
#sponsors
 +
{
 +
float: left;
 +
width: 330px;
 +
margin-right: 24px;
 +
}
 +
#sponsors .style4
 +
{
 +
padding-top: 10px;
 +
}
 +
#dates
 +
{
 +
float: left;
 +
width: 370px;
 +
padding: 0px 20px;
 +
}
 +
#updates
 +
{
 +
float: left;
 +
width: 200px;
 +
}
 +
p, ol, ul {
 +
margin-top: 0px;
 +
}
 +
p {
 +
line-height: 180%;
 +
}
 +
a {
 +
color: #0000FF;
 +
}
 +
a:hover {
 +
text-decoration: none;
 +
}
 +
a img {
 +
border: none;
 +
}
 +
ul.style3
 +
{
 +
margin: 0;
 +
padding: 0;
 +
overflow: hidden;
 +
list-style: none;
 +
color: #6c6c6c
 +
}
 +
ul.style3 li
 +
{
 +
padding: 16px 0px 0px 0px;
 +
margin: 0 0 1em 0;
 +
}
 +
ul.style3 p
 +
{
 +
margin: 0;
 +
}
 +
ul.style3 a
 +
{
 +
display: block;
 +
text-decoration: none;
 +
color: #2D2D2D;
 +
}
 +
ul.style3 a:hover
 +
{
 +
text-decoration: underline;
 +
}
 +
ul.style3 h3
 +
{
 +
padding: 10px 0px 5px 0px;
 +
text-transform: uppercase;
 +
font-size: 14px;
 +
font-weight: 300;
 +
color: #FFFFFF;
 +
}
 +
ul.style3 .first
 +
{
 +
padding-top: 0;
 +
background: none;
 +
}
 +
ul.style3 .date
 +
{
 +
float: left;
 +
position: relative;
 +
width: 66px;
 +
height: 64px;
 +
margin: 0.5em 1.5em 0em 0.5em;
 +
padding: 20px 0em 0em 0em;
 +
background: #262626;
 +
border-radius: 5px;
 +
box-shadow: 0px 0px 0px 5px rgba(255,255,255,0.1);
 +
line-height: normal;
 +
text-align: center;
 +
text-transform: uppercase;
 +
text-shadow: 0px 1px 0px rgba(0,0,0,.2);
 +
font-size: 12px;
 +
font-weight: 400;
 +
color: #FFF;
 +
}
 +
ul.style3 .date:after
 +
{
 +
content: '';
 +
display: block;
 +
position: absolute;
 +
left: 0;
 +
top: 0;
 +
width: 100%;
 +
height: 100%;
 +
border-radius: 6px;
 +
}
 +
ul.style3 .date b
 +
{
 +
margin: 0;
 +
padding: 0;
 +
display: block;
 +
margin-top: -5px;
 +
font-size: 24px;
 +
font-weight: 700;
 +
color: #FFFFFF;
 +
}
 +
ul.style3 .date a
 +
{
 +
color: #FFFFFF !important;
 +
}
 +
ul.style3 .date a:hover
 +
{
 +
text-decoration: none;
 +
}
 +
ul.style4
 +
{
 +
margin: 0px;
 +
padding: 0px;
 +
list-style: none;
 +
}
 +
ul.style4 li
 +
{
 +
padding: 10px 0px 20px 0px;
 +
border-top: 1px solid rgba(255,255,255,0.3);
 +
}
 +
ul.style4 a
 +
{
 +
color: #2D2D2D;
 +
text-decoration: underline;
 +
}
 +
ul.style4 .first
 +
{
 +
padding-top: 0px;
 +
border-top: none;
 +
}
 +
/* Button Style 1 */
 +
.button-style {
 +
display: inline-block;
 +
margin-top: 20px;
 +
padding: 7px 20px;
 +
background: #272727;
 +
border-radius: 5px;
 +
text-decoration: none;
 +
text-transform: uppercase;
 +
color: #FFFFFF;
 +
}
 +
.button-style a {
 +
color:#66CCFF;
 +
}
 +
.button-style-alt
 +
{
 +
background: #E94730;
 +
padding: 15px 20px;
 +
font-size: 14px;
 +
font-weight: 600;
 +
}
 +
</style>
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since minicells are inherently safer than live bacteria, they lower the risk of infection, which is especially important for the young, elderly, or immunocompromised. The safeguard modifications we will implement will add to this innate safety, further lowering associated risks and enhancing minicells’ usability as a safe chassis for therapeutic use.
+
</head>
-
</p>
+
<body>
 +
<div class="igemlogo">
 +
<a href="https://2013.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/igem.org/1/17/IGEM_basic_Logo_white_stylized.png" width="70"> </a>
 +
</div>
 +
<div class="topbanner">
 +
  <div id="logo">
 +
<p id="VGEM"><a href="https://2013.igem.org/Team:Virginia"><span>V</span>GEM</a></p>
 +
<p><a href="http://www.virginia.edu/"> University of Virginia</a></p>
 +
</div>
 +
  <div id="menu11">
 +
    <ul>
 +
        <li>
 +
                <span class="title">Home</span>
 +
                <span class="text"><a href="https://2013.igem.org/Team:Virginia">The start</a></span>
 +
        </li>
 +
        <li>
 +
        <span class="title">Project</span>
 +
                <span class="text">
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Project_Overview">Overview</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Background">Background</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Parts">Parts</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Results">Results</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Modeling">Modeling</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Software">Software</a></p>
-
<p></p>
+
                <p><a href="https://2013.igem.org/Team:Virginia/Chassis_Improvements">Chassis Improvements</a></p></span>
-
<h6><b>Sources</b></h6>
+
        </li>
-
<h6>Anisimov, A., Shalkhutdinova, R., Pan, L., Feodorova, V., Savostina, E., Bystrova, O., Lindner, B., & Mokrievich, A. (2007). Effect of deletion of the lpxm gene on virulence and vaccine potential of yersinia pestis in mice. Journal of Medical Microbiology, 56(4), 443-53. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17374882?dopt=AbstractPlus </h6>
+
        <li>
-
 
+
                <span class="title">Notebook</span>
-
<h6>Frazer, A. & Curtiss, 3rd R. (1975). Production, properties and utility of bacterial minicells. Current Topics in Microbiology and Immunology. 69, 1–84.</h6>
+
                <span class="text">
-
 
+
                <p><a href="https://2013.igem.org/Team:Virginia/Notebook_Overview">Overview</a></p>
-
<h6>Kolodziejek, A., Schnider, D., Rohde, H., Wojtowicz, A., Bohach, G., Minnich, S., & Hovde, C. (2010). Outer membrane protein x (ail) contributes to yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length. Infectious Immunology, 78(12), 5233-43. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20837715</h6>
+
                <p><a href="https://2013.igem.org/Team:Virginia/Notebook">Notebook</a></p>
-
 
+
                <p><a href="https://2013.igem.org/Team:Virginia/Protocols">Protocols</a></p>
-
<h6>MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., et al. (2007). Bacterially derived 400 nm particles for encapsulation and cancer cells targeting of chemotherapeutics. Cancer Cell, 11(5), 431-45. </h6>
+
                <p><a href="https://2013.igem.org/Team:Virginia/Gallery">Gallery</a></p></span>
-
 
+
        </li>
-
<h6>Ward, J.E., Lutkenhaus, J. (1985). Overproduction of FtsZ induces minicell formation in Escherichia-coli. Cell, 42(3), 941-9.  
+
        <li>
-
</h6>
+
                          <span class="title">Human Practices</span>
 +
                <span class="text">
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Human_Practices_Overview">Overview</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Safety Considerations">Safety Considerations</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/High_School_Education_Series">High School Education Series</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Documentary">Documentary</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Media_Coverage">Media Coverage</a></p>
 +
</span>
 +
        </li>
 +
        <li>
 +
                <span class="title">Team</span>
 +
  <span class="text">
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Team_Overview">Overview</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Bios">Bios</a></p>
 +
                <p><a href="https://igem.org/Team.cgi?year=2013&team_name=Virginia">Profile</a></p>
 +
                <p><a href="https://2013.igem.org/Team:Virginia/Sponsors">Sponsors</a></p>
 +
      <p><a href="https://2013.igem.org/Team:Virginia/Attributions">Attributions</a></p></span></li></ul></div></div>
 +
<div class="slidingpics">
 +
    <div id="images">
 +
    <img id="image1" src="https://static.igem.org/mediawiki/2013/d/d3/New_banner.png" />
 +
    <img id="image2" src="https://static.igem.org/mediawiki/2013/a/ae/Screen_Shot_2013-09-27_at_11.47.23_PM.png" />
 +
    <img id="image3" src="https://static.igem.org/mediawiki/2013/2/2b/Screen_Shot_2013-09-27_at_11.10.07_PM.png" />
 +
    <img id="image4" src="https://static.igem.org/mediawiki/2013/e/e1/Screen_Shot_2013-09-27_at_11.32.44_PM.png" />
 +
    <img id="image5" src="https://static.igem.org/mediawiki/2013/8/8d/Slide_4-01.png" />
 +
    </div>
 +
    <div id="slider">
 +
    <a href="#image1">1</a>
 +
    <a href="#image2">2</a>
 +
    <a href="#image3">3</a>
 +
    <a href="#image4">4</a>
 +
    <a href="#image5">5</a>
 +
    </div>
 +
<!--<div id="picbox"><img src="http://24.media.tumblr.com/97a47d3aa55da6f5985d81b4fd7dfb27/tumblr_mp2gt0CjGe1sxgpaeo1_1280.jpg" width="1000" height="350"/></div>-->
 +
</div>
 +
<div class="fourfocus">
 +
  <div id="boxes"><div id="fbox1"><a href="https://2013.igem.org/Team:Virginia/Project_Overview"><img src="https://static.igem.org/mediawiki/2013/c/c2/Vgemplates.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Project</h2>
 +
<p>Learn more about the exciting development of minicells as a safe and effective chassis.</p>
 +
  </div>
 +
  <div id="fbox2"><a href="https://2013.igem.org/Team:Virginia/Notebook"><img src="https://static.igem.org/mediawiki/2013/thumb/4/4e/Vgemopennotebook.jpg/800px-Vgemopennotebook.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Notebook</h2>
 +
<p>See how we spent our summer of science.</p>
 +
  </div>
 +
<div id="fbox3"><a href="https://2013.igem.org/Team:Virginia/Human_Practices_Overview"><img src="https://static.igem.org/mediawiki/2013/8/86/VgemClass_7.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Human Practices</h2>
 +
<p>Discover the local and global impact our iGEM team has made.</p>
 +
</div>
 +
<div id="fbox4"><a href="https://2013.igem.org/Team:Virginia/Team_Overview"><img src="https://static.igem.org/mediawiki/2013/thumb/5/59/VgemTeam_photo_2.jpg/546px-VgemTeam_photo_2.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Team</h2>
 +
<p>Meet the brains and brawn behind the project.</p>
 +
</div></div>
 +
</div>
 +
<div class="bottom">
 +
<div id="featured-wrapper">
 +
<div id="sponsors">
 +
<div id="btitle"><p><b>Sponsors</b><br/>
 +
<span><font color="white">Funding the Science</font></span></p></div>
 +
<p><font color="white">Without our sponsors, this year's iGEM team would not be in existence. Thank you.</font></p>
 +
<ul class="style4">
 +
<li class="first"><a href="http://www.virginia.edu/vpr/biography.html"><font color="white">Tom Skalak, Vice President of Research at UVA</font></a></li>
 +
<li><a href="http://medicine.virginia.edu/"><font color="white">UVA Medical School</font></a></li>
 +
<li><a href="http://seas.virginia.edu/"><font color="white">UVA School of Engineering and Applied Science</font></a></li>
 +
                <li><a href="http://artsandsciences.virginia.edu/home/index.html"><font color="white">UVA College of Arts and Sciences</font></a></li>
 +
                <li><a href="#"><font color="white">Alumni Lacy Fund</font></a></li>
 +
</ul>
 +
<a href="https://2013.igem.org/Team:Virginia/Sponsors" class="button-style"><font color="#66ccff">Official Sponsors Page</font></a> </div>
 +
<div id="dates">
 +
<p id="btitle"><b>Competition Events</b><br/>
 +
<span><font color="white">Next Stop: MIT!</font></span></p>
 +
<ul class="style3">
 +
<li class="first">
 +
<p class="date">September<b>18</b></p>
 +
<h3>Biobrick Part Due</h3>
 +
<p><a href="http://parts.igem.org/Main_Page"><font color="white">All DNA due to the iGEM registry.</font></a></p>
 +
</li>
 +
<li>
 +
<p class="date">October<b>4-6</b></p>
 +
<h3>North America Regional Jamboree</h3>
 +
<p><a href="http://www.utoronto.com/"><font color="white">University of Toronto, Ontario, CA</font></a></p>
 +
</li>
 +
<li>
 +
<p class="date">November<b>1-4</b></p>
 +
<h3>World Championship Jamboree</h3>
 +
<p><a href="http://www.mit.edu/"><font color="white">MIT, Cambridge, USA</font></a></p>
 +
</li>
 +
<li>
 +
</ul>
 +
</div>
 +
<div id="updates">
 +
<p id="btitle"><b>Recent Updates</b><br />
 +
<span><font color="white">Team Progress</font></span></p>
 +
<ul class="style4">
 +
<li class="first"><font color="white">Advancing to Worlds!</font> <p><font color="white">Awarded Gold Medal & Best Human Practices Advance at Regionals</font></p></li>
 +
<li><a href="https://news.virginia.edu/content/uva-student-team-advances-global-genetic-engineering-championship"><font color="white">Featured in UVA Today!</font></a></li>
 +
<li><a href="http://wuvaonline.com/uva-students-win-genetics-competition/"><font color="white">Featured on WUVA!</font></a></li>
 +
<li><a href="http://www.nbc29.com/story/23733058/uva-genetic-engineering-team-developing-high-school-class?autoStart=true&topVideoCatNo=default&clipId=9431958"><font color="white">Featured on NBC 29!</font></a></li>
 +
<li><a href="http://www.dailyprogress.com/news/local/dna-workshop-at-renaissance-school/collection_9f7522e8-2242-11e3-a7a5-0019bb30f31a.html?mode=nogs"><font color="white">Featured in Daily Progress!</font></a></li>
 +
<li><a href="http://www.c-ville.com/bright-young-things-uvas-self-directed-synthetic-biology-stars/"><font color="white">Featured in CVille Weekly!</font></li>
 +
</ul>
 +
</div>
 +
</div>
 +
<div class="footer">
 +
<h3>&nbsp;</h3>
 +
<h3>Contact</h3>
 +
<p>Questions? Comments? Email us at <a href="virginia.igem@gmail.com">virginia.igem@gmail.com</a></p>
 +
</div>
 +
   
 +
<p>&nbsp;</p>
 +
</body>
</html>
</html>
-
|-
 
-
|
 
-
|}
 
-
 
-
<!--- The Mission, Experiments --->
 

Latest revision as of 01:53, 29 October 2013

VGEM Welcomes You!

1 2 3 4 5

Project

Learn more about the exciting development of minicells as a safe and effective chassis.

Notebook

See how we spent our summer of science.

Human Practices

Discover the local and global impact our iGEM team has made.

Team

Meet the brains and brawn behind the project.

 

Contact

Questions? Comments? Email us at virginia.igem@gmail.com

 

Retrieved from "http://2013.igem.org/Team:Virginia"